Cormorant Asset Management, LP Q2 2018 Filing
Filed August 14, 2018
Portfolio Value
$1.4T
Holdings
57
Report Date
Q2 2018
Filing Type
13F-HR
All Holdings (57 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | NKTREURNEKTAR THERAPEUTICS | 3,328,400 | $162.5B | 12.03% | Call |
| 2 | APLSAPELLIS PHARMACEUTICALS INC | 4,312,498 | $94.9B | 7.02% | |
| 3 | MRTXEURMIRATI THERAPEUTICS INC | 1,918,350 | $94.6B | 7.00% | |
| 4 | ANABANAPTYSBIO INC | 1,233,422 | $87.6B | 6.48% | |
| 5 | IFRXINFLARX NV | 1,487,265 | $48.0B | 3.55% | |
| 6 | —DICERNA PHARMACEUTICALS INC | 3,600,954 | $44.1B | 3.26% | |
| 7 | —AVROBIO INC | 1,507,783 | $43.1B | 3.19% | |
| 8 | AUTLAUTOLUS THERAPEUTICS PLC | 1,525,587 | $40.9B | 3.02% | |
| 9 | —MYOKARDIA INC | 767,363 | $38.0B | 2.81% | |
| 10 | SG7SAGE THERAPEUTICS INC | 239,619 | $37.5B | 2.78% | |
| 11 | 2L9BLUEPRINT MEDICINES CORP | 550,000 | $34.9B | 2.58% | |
| 12 | —QUOTIENT LTD | 4,290,852 | $34.5B | 2.55% | |
| 13 | GTHXEURG1 THERAPEUTICS INC | 719,985 | $31.3B | 2.32% | |
| 14 | RCKTROCKET PHARMACEUTICALS, INC | 1,519,890 | $29.8B | 2.21% | |
| 15 | TBPHTHERAVANCE BIOPHARMA INC | 1,300,000 | $29.5B | 2.18% | |
| 16 | 1T7TRICIDA INC | 934,588 | $27.9B | 2.07% | |
| 17 | KZRKEZAR LIFE SCIENCES INC | 1,572,910 | $27.2B | 2.01% | |
| 18 | SPPIUSDSPECTRUM PHARMACEUTICALS INC | 1,200,000 | $25.2B | 1.86% | |
| 19 | ASNDASCENDIS PHARMA A S | 371,739 | $24.7B | 1.83% | |
| 20 | —TESARO INC | 550,000 | $24.5B | 1.81% | |
| 21 | SLDBSOLID BIOSCIENCES INC | 685,956 | $24.4B | 1.81% | |
| 22 | OMEROMEROS CORP | 1,314,118 | $23.8B | 1.76% | |
| 23 | ARGXARGENX SE | 278,536 | $23.1B | 1.71% | |
| 24 | ARNAEURARENA PHARMACEUTICALS INC | 450,000 | $19.6B | 1.45% | |
| 25 | NBIXNEUROCRINE BIOSCIENCES INC | 191,112 | $18.8B | 1.39% | |
| 26 | VNDAVANDA PHARMACEUTICALS INC | 957,821 | $18.2B | 1.35% | |
| 27 | OMEROMEROS CORP | 969,000 | $17.6B | 1.30% | Call |
| 28 | RETAEURREATA PHARMACEUTICALS INC | 450,000 | $15.7B | 1.16% | |
| 29 | KNSAKINIKSA PHARMACEUTICALS LTD | 831,000 | $13.8B | 1.02% | |
| 30 | INCYINCYTE CORP | 200,000 | $13.4B | 0.99% | |
| 31 | CLSDUSDCLEARSIDE BIOMEDICAL INC | 1,200,000 | $12.8B | 0.95% | |
| 32 | —AUDENTES THERAPEUTICS INC | 322,945 | $12.3B | 0.91% | |
| 33 | QTRXQUANTERIX CORP | 847,788 | $12.2B | 0.90% | |
| 34 | INSPINSPIRE MED SYS INC | 325,000 | $11.6B | 0.86% | |
| 35 | —BIOHAVEN PHARMACTL HLDG CO L | 284,735 | $11.3B | 0.83% | |
| 36 | ARRYEURARRAY BIOPHARMA INC | 668,743 | $11.2B | 0.83% | |
| 37 | —GEMPHIRE THERAPEUTICS INC | 1,041,635 | $10.6B | 0.79% | |
| 38 | ACRSACLARIS THERAPEUTICS INC | 525,538 | $10.5B | 0.78% | |
| 39 | —ABEONA THERAPEUTICS INC | 549,404 | $8.8B | 0.65% | |
| 40 | ZLABZAI LAB LTD | 333,166 | $7.7B | 0.57% | |
| 41 | —CONTRAFECT CORP | 3,392,234 | $7.5B | 0.55% | |
| 42 | —EIDOS THERAPEUTICS INC | 385,846 | $7.5B | 0.55% | |
| 43 | HRTXHERON THERAPEUTICS INC | 191,108 | $7.4B | 0.55% | |
| 44 | COLLCOLLEGIUM PHARMACEUTICAL INC | 286,668 | $6.8B | 0.51% | |
| 45 | —TRANSLATE BIO INC | 454,550 | $5.8B | 0.43% | |
| 46 | ITRMITERUM THERAPEUTICS PLC | 500,000 | $5.4B | 0.40% | |
| 47 | GBYSANGAMO THERAPEUTICS INC | 382,192 | $5.4B | 0.40% | |
| 48 | NERVGBPMINERVA NEUROSCIENCES INC | 607,903 | $5.0B | 0.37% | |
| 49 | XLRNACCELERON PHARMA INC | 71,667 | $3.5B | 0.26% | |
| 50 | TREURTRILLIUM THERAPEUTICS INC | 573,208 | $3.4B | 0.25% | |
| 51 | —INTEC PHARMA LTD JERUSALEM | 773,816 | $3.4B | 0.25% | |
| 52 | —MARINUS PHARMACEUTICALS INC | 478,111 | $3.4B | 0.25% | |
| 53 | SRRKSCHOLAR ROCK HOLDING CORP | 210,078 | $3.3B | 0.24% | |
| 54 | MGTXMEIRAGTX HOLDINGS PLC | 238,580 | $2.7B | 0.20% | |
| 55 | PTGXPROTAGONIST THERAPEUTICS INC | 382,139 | $2.6B | 0.19% | |
| 56 | —ONCOBIOLOGICS INC | 416,666 | $20.0M | 0.00% | |
| 57 | —CELLECTAR BIOSCIENCES INC | 52,999 | $10.0M | 0.00% |